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Introduction: The technique of stenting malignant obstructing colorectal lesions is established as an
acceptable treatment with a low morbidity and mortality. This paper reviews our experience in stenting
malignant colorectal obstruction and compares this group with those who underwent emergency
surgery as their primary intervention.
Methods: A retrospectively kept database over four years was reviewed and patients who had undergone
either stenting or emergency surgery for a malignant colorectal obstruction were identiﬁed. These
patients’ notes were retrieved and reviewed.
Results: During the duration of study, a total of 29 stents were placed in 28 patients, with a mean age of
78 y (range 59e96 years). Patients generally had signiﬁcant co-existing morbidity, with a median ASA
score of 2.5. The timing of stent placement was a mean of 3.4 days (1e9 days) after presentation,
including time for relevant investigation and diagnosis. Mean length of hospital stay was 9.8 days (2e36
days). In the emergency operation category, during the period of study, a total of 38 patients had
operations for large bowel obstruction, either because the lesion was not suitable for stenting, or the
personnel for stenting were not available. These patients ranged in age from 45 to 96 years, with a mean
age of 72.4 years. Patients in this group were generally a little ﬁtter than the stented group, with
a median ASA grade of 2, and 14/38 patients were ASA1 (the largest group). Despite this Post-operative
recovery was slow with these patients, the average length of stay being 16 days (range 8e66 days).
Conclusions: In this study, we report our data on the ﬁrst four years of stenting malignant bowel
obstruction. It is a feasible and acceptable means of treatment, and we have demonstrated comparable
morbidity and mortality to that reported in medical literature. The technique may avoid the need for
emergency operation with its concomitant risks, lengthy in-patient stay, and high likelihood for a stoma.
We would advocate the use of self expanding metal stents where appropriate in the management of large
bowel obstruction.
 2010 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
The technique of stenting malignant obstructing colorectal
lesions is established as an acceptable treatment since it was ﬁrst
described in 1991.1 Approximately 50% of patients in this chal-
lenging category are aged 70e89years2 and they carry a signiﬁcant
30-day mortality and morbidity.3,4
Expandingmetal stents are placed across an obstructing tumour
giving relief from their symptoms. This procedure either allows
time for the patient to be optimised for deﬁnitive surgery (bridge)N.J. Phillips), Julian.elford@
A.J.G. Miles).
ciates Ltd. Published by Elsevier Ltor is used as an effective palliative procedure for inoperable
cancers. Since Tejero et al. ﬁrst coined the term ‘bridge to surgery’
in 19946 larger studies have reported patients being treated in this
two-stage procedure.7,8 A meta-analysis of studies has shown that
stenting has a low mortality rate (1%) and a successful palliation
rate (90%) in patients thus treated.5
In the bridge to surgery group, complication rates are low
(perforation rate 0e5%, stent migration 0e9.5%, and re-obstruction
prior to surgery 0e4.7%).7e9 Up to 95% of patients had a primary
anastomosis at subsequent operation, negating the need for
a stoma.8
In recent times, laparoscopic-assisted surgery for colorectal
cancer resections has gained increasingly widespread acceptance,
with lower rates of morbidity. A recent study showed that blood
loss and post-operative pain was less following laparoscopicd. All rights reserved.
Fig. 2. Distribution of sites of obstructing colonic cancer.
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eating.10 This resulted in the hospital stay being, on average, 2 days
shorter. Initial concerns, however, centred around the oncological
clearance and long-term outcomes using this technique.11 More
recently, however, data has been produced showing there appears
to be no signiﬁcant difference in overall or disease-free survival,
with one study demonstrating a recurrence rate of 23% in both
open and laparoscopic groups.12
This paper reviews our experience in stenting malignant colo-
rectal obstruction and compares this group with those who
underwent emergency surgery as their primary intervention.
2. Methods
Between 2002 and 2006 a retrospective database of all patients undergoing
emergency bowl surgery or endscopic stenting has been kept by the hospital colo-
rectal co-ordinator and the department of radiology respectively. These databases
have recorded patient demographics and technical details concerning the relevant
procedure.
These patients’ records were retrieved and data concerning age, sex, ASA grade,
site of tumour, type of operation, formation of stoma, ITU admission, overall length
of stay and complications were recorded as appropriate. Additionally, similar data
was obtained concerning second elective procedures (such as reversal of stoma or
those requiring operation after failure of stenting). Patients undergoing a lapa-
rotomy for bleeding or perforation were excluded from this study.
3. Results
During the duration of study, a total of 29 stents were placed in
28 patients, with a mean age of 78 y (range 59e96 years). Patients
generally had signiﬁcant co-existing morbidity, with a median ASA
score of 2.5. The timing of stent placement was a mean of 3.4 days
(1e9 days) after presentation, including time for relevant investi-
gation and diagnosis. Mean length of hospital stay was 9.8 days
(2e36 days); see Fig. 1.
The commonest anatomical site (Fig. 2) for an obstructing lesion
was the sigmoid colon (64%), with other sites including recto-
sigmoid (7%), descending colon (18%), and transverse colon (11%).
15/28 patients died during the course of the study. The mean
survival post-stenting was 10.7 months (range 5 dayse28 months).
13 patients were still alive at the end of the study.
Six patients (21%) had complications related to their admission.
One patient was unable to be stented due to the inability to cross
the obstruction with a guide wire. He underwent a Hartmann’s
procedure, and died of multi-organ failure and sepsis on the ﬁfth
post-operative day on ITU. This was the only in-patient death. The
only other patient admitted to ITU during this time (for a total of 10
days) developed pneumonia, but responded well to treatment, was
discharged on day 28, and subsequently underwent successful
laparoscopic resection. One stent migrated, causing obstruction,Fig. 1. Total length of staynecessitating a subtotal colectomy, whilst one patient re-presented
with obstruction due to tumour growth around the end of the stent.
This patient had a second stent inserted with good symptom relief.
Two stent perforations occurred, both in the palliative group.
One was initially discharged well on day 4, but returned two weeks
later andwas found to have a pericolic abscess at the tip of the stent
where the proximal end had caused a small contained perforation.
He was treated conservatively with i.v. antibiotics and made a good
recovery. The other patient developed peritonitis within 12 h of
stenting, and was taken for a Hartmann’s procedure.
Nine patients subsequently underwent elective surgery. One
open left hemicolectomy was performed, and two patients had an
open extended right hemicolectomy, although one was found to be
palliative at operation. This patient had a further laparotomy six
months later for obstructive symptoms, where an ileo-transverse
bypass was performed. One patient had a Hartmann’s procedure.
Five patients had a laparoscopic anterior resectionwith primary
anastomosis and no stoma. This subset of patients, whowere found
to have no metastatic disease, had a mean age of 79 years (range
71e88), and was operated on 69 days after being stented
(range 29e135). Peri-operative stay for these patients was 9 days
(range 7e12). No major morbidity was seen in these ﬁve patients,
although one developed a minor chest infection requiring antibi-
otics and chest physiotherapy.
During the period of study, a total of 38 patients had operations
for large bowel obstruction, either because the lesion was not suit-
able for stenting, or the personnel for stenting were not available.
These patients ranged in age from 45 to 96 years, with a mean age
of 72.4 years. Patients in this group were generally a little ﬁtter
than the stented group, with a median ASA grade of 2, and 14/38
patients were ASA1 (the largest group). Despite this, three patients
(7.9%) died in hospital, within two weeks of surgery. One patientfor stented patients.
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in the post-operative period, one succumbed to multi-organ
failure, and one patientwas septic, almostmoribund on arrival (ASA
5), and died on ITU on day 9 post-operatively.
Timing of surgery was a mean of 3 days after presentation,
(range 1e7 days), allowing for resuscitation and diagnostic testing.
23/38 patients had a right hemicolectomy to resect right sided or
transverse colon lesions, while one patient had a palliative bypass.
Two trephine colostomies were brought out in elderly patients with
signiﬁcant co-morbidity, and two subtotal colectomies performed
in patients whose caecum was critically distended at operation.
Ten left sided lesions were resected, six of whom had a Hartmann’s
procedure, leaving four with a primary resection and anastomosis,
two with a covering stoma, and one with a caecostomy.
Seventeen patients required an ITU bed post-operatively, for an
average of 4 days (range 1e10 days). Of these, eight were ventilated
post-operatively for an average of 2 days (range 1e5 days).
Ten patients had stomas, and stoma training alone extended the
hospital stay by an average of 3.3 days per patient, after they were
otherwise considered ﬁt for surgical discharge.
Post-operative recovery was slow with these patients, the
average length of stay being 16 days (range 8e66 days).
Signiﬁcant morbidity was seen in 12/38 patients (32%). Three
had a myocardial infarction, ﬁve had septic or infective complica-
tions, and one patient went into retention and required a TURP as
an in-patient. Two patients were re-operated on during their index
admission, one for a dehiscence, and one for revision of stoma.
Three patients were admitted for further surgery at a later date:
one for resection of a liver metastasis after 32 weeks (at a different
hospital), and two for reversal of stoma, one of which developed
a ﬁstula at the closure site, necessitating ITU admission for 11 days
and eventually discharged after 7 weeks.
As expected, pathological staging of the resected tumours was
advanced, with 13 classiﬁed as Dukes B, and 25 classiﬁed as Dukes
C. 21 patients were considered to have had a curative procedure
(55%), and were still alive at the end of the study, up to 4 years later.
4. Discussion
Malignant large bowel obstruction remains a challenging clin-
ical problem in the 21st century, with high levels of morbidity and
mortality. The ACPGBI audit of over 8000 patients showed that
emergency operations for this range of conditions resulted in
a mortality rate of 20%.13
This retrospective audit does not directly compare a matched
population for patients undergoing stenting versus operation. We
have studied all patients treated for large bowel obstruction over
four years, with what we considered the best means available to
each patient at the time of presentation. Our mortality rate for
patients who underwent operationwas 7.9%; this was despite being
a group with better ASA grading compared to those who were
stented. A signiﬁcant number of this group, however, had a right
hemicolectomy, perhaps imparting less insult to patients than
those undergoing left sided resections. These patients are not
amenable to stenting by current techniques. Despite, this however,
it still demonstrates that operative intervention has its risks in
terms of mortality and morbidity, with a complication rate of 32%.
Set against this is our procedural complication rate of 18% for the
stented group. This includes problems such as migration, tumour
overgrowth, failure to stent (each one patient, 4%), and perforation
(7% - two patients). Such ﬁgures are comparable to those quoted
in large systematic reviews, with rates of migration and re-
obstruction of about 10%, and perforation and bleeding around
5%.14,15 Our series looks at the ﬁrst four years of practice of stenting
in a district general hospital, and encompasses the ‘learning curve’associated with a new technique. Despite this, our ﬁgures are
comparable to those achieved in the medical literature.
The average length of stay for stented patients was 9 days,
allowing for investigation, treatment and resolution of their symp-
toms. A longer period of 16 dayswas required for those patientswho
underwent surgery. Whilst the two groups can not be compared
directly, it is clear that stented patients are discharged around
a week earlier than those who had surgery. If we had looked at
amatched population, comparing stents against left sided resection,
then this differencemay have been even greater, withmore patients
requiring stoma training prior to discharge.17 patients required ITU
stay for a cumulative total of 69 days. With an ITU bed costing
approximately £1100e£1400 per day (government ﬁgures), this
represents a total cost of over £86,000 on intensive care treatment
for this group of patients alone.
Any treatment which may allow for faster discharge from
hospital should be considered for its potential. Stenting malignant
bowel obstruction may have a signiﬁcant impact on hospital bed
occupancy, compared to emergency operation, at a time when bed
shortages are an increasing problem. It has been suggested that
the cost of occupying an NHS bed for a day can be calculated at
over £300. Whilst stenting may allow for faster discharge, the cost
of equipment will offset this to some extent. One study estimated
that the cost of materials for stenting worked out at an average of
just over €1700 (£1150 approx) per patient.16 Overall, this group
found that defunctioning alone was cheaper by €132 (£91) per in-
patient episode compared to stenting, but did not look at the on-
going costs and morbidity of stoma care once discharged from
hospital.
In this study, we report our data on the ﬁrst four years of
stentingmalignant bowel obstruction. It is a feasible and acceptable
means of treatment, and we have demonstrated comparable
morbidity and mortality to that reported in medical literature. The
technique may avoid the need for emergency operation with its
concomitant risks, lengthy in-patient stay, and high likelihood for
a stoma. We would advocate the use of self-expanding metal stents
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